Tzafra Cohen

USPTO Granted Patents = 8 (Patent Applications = 4)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 18(Granted Patents)

Company Filing History:

Nextferm Technologies Ltd.

patent

4. 1 out of 7

Multi-gene Vascular Systems, Ltd.

patents

Years Active: 2009-2023

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11597908 - Freeze-resistant yeast and uses thereof (2023-03-07),

2. 9561207 - Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation (2017-02-07),

3. 9433599 - Methods and lipid compositions for promoting development of gut flora (2016-09-06),

4. 9107439 - Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation (2015-08-18),

5. 8980949 - Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation (2015-03-17),

6. 8772270 - Treatment methods requiring phyto-ingredients (2014-07-08),

7. 7767201 - Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same (2010-08-03),

8. 7524493 - Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension (2009-04-28),

Title: Tzafra Cohen: Innovator in Yeast and Gastrointestinal Health

Introduction

Tzafra Cohen is a notable inventor based in Haifa, Israel, recognized for his contributions to the fields of yeast technology and gastrointestinal health. With a total of eight patents to his name, Cohen has made significant advancements that have practical applications in food production and health.

Latest Patents

Cohen's latest patents include innovations such as freeze-resistant yeast and its various uses. This freeze-resistant baker's yeast is designed for the preparation of fresh or frozen dough products, including bread. The yeast strains can be obtained from specific deposited strains through breeding methods. Additionally, Cohen has developed lipid compositions aimed at treating gastrointestinal disorders and promoting intestinal development and maturation. These compositions can be utilized in nutritional, pharmaceutical, or nutraceutical formulations to prevent and treat gastrointestinal diseases.

Career Highlights

Throughout his career, Tzafra Cohen has worked with several companies, including Enzymotec Ltd. and M.G.V.S. Ltd. His work has focused on enhancing the functionality of yeast and developing health-promoting compositions, showcasing his commitment to innovation in these fields.

Collaborations

Cohen has collaborated with notable individuals such as Yael Lifshitz and Gai Ben Dror, contributing to the advancement of his research and inventions.

Conclusion

Tzafra Cohen's innovative work in yeast technology and gastrointestinal health demonstrates his significant impact on both food science and health. His patents reflect a dedication to improving products that benefit consumers and the food industry alike.

This text is generated by artificial intelligence and may not be accurate.